Focus, Forward
Our focus is on unlocking the full therapeutic potential of the NO-cGMP pathway to address a broad range of serious CNS diseases.
We have the expertise, team and determination to bring innovative medicines forward for patients.
Our Pipeline
Our pipeline is focused on programs for serious CNS diseases.
Discovery
DISC
IND Enabling
IND
Phase 1
PH1
Phase 2
PH2
Olinciguat
Vascular sGC Stimulator
Olinciguat
Vascular sGC Stimulator
Praliciguat
Systemic
sGC Stimulator
Praliciguat
Systemic
sGC Stimulator
IW - 6463
Central Nervous System
sGC Stimulator
IW - 6463
Central Nervous System
sGC Stimulator
Liver
Liver-targeted
sGC Stimulator
Liver
Liver-targeted
sGC Stimulator
Lung
Lung-targeted
sGC Stimulator
Lung
Lung-targeted
sGC Stimulator
Learn more about neurophysiology and the importance of NO-sGC-cGMP signaling in the CNS.
Leaders in Drug Discovery and Development
We are world leaders in targeting the nitric oxide-cGMP pathway in the CNS.
Our team has an exceptional track record bringing meaningful therapies to patients.